Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Opioid antagonists for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2. Review.

PMID:
21154349
2.

Acamprosate for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD004332. doi: 10.1002/14651858.CD004332.pub2. Review.

PMID:
20824837
3.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD001867.

PMID:
15674887
4.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2002;(2):CD001867. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD001867.

PMID:
12076425
5.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2000;(3):CD001867. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001867.

PMID:
10908513
6.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec. Review.

7.

Sustained-release naltrexone for opioid dependence.

Lobmaier P, Kornør H, Kunøe N, Bjørndal A.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006140. doi: 10.1002/14651858.CD006140.pub2. Review.

PMID:
18425938
8.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001333. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD001333.

PMID:
16437431
9.

Nalmefene. Alcohol dependence: no advance.

[No authors listed]

Prescrire Int. 2014 Jun;23(150):150-2.

PMID:
25121147
10.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.

Alcohol Clin Exp Res. 2007 Jul;31(7):1179-87. Epub 2007 Apr 19.

PMID:
17451401
11.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
12.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

13.

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.

Mann K, Bladström A, Torup L, Gual A, van den Brink W.

Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11.

PMID:
23237314
14.

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB.

Arch Gen Psychiatry. 1999 Aug;56(8):719-24.

PMID:
10435606
15.

Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.

Lobmaier PP, Kunøe N, Gossop M, Waal H.

CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. Review.

PMID:
21554565
16.

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

Soyka M, Rösner S.

Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. Review.

PMID:
19630726
17.

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.

PMID:
23562264
18.

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.

Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M.

JAMA Psychiatry. 2015 May;72(5):430-7. doi: 10.1001/jamapsychiatry.2014.3053.

PMID:
25760804
19.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
20.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966

Supplemental Content

Support Center